RC
Ruby Chaudhary
About Ruby Chaudhary
Data last updated:
Ruby Chaudhary is a Director at Vilarsh Healthcare Private Limited (since 2018) and Director at Viovas Pharma Private Limited (since 2025). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹20.79 Cr; the largest is Vilarsh Healthcare Private Limited at ₹19.52 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vilarsh Healthcare Private Limited U74999DL2018PTC332248 | Director | 10 Apr 2018 | 2018 | ₹19.52 Cr (FY 2025) | Active |
 Viovas Pharma Private Limited U47721DL2023PTC417099 | Director | 28 Apr 2025 | 2023 | ₹1.27 Cr (FY 2025) | Active |
Board colleagues of Ruby Chaudhary
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vijay Pal Solanki | 08080795 | Vilarsh Healthcare Private Limited , Viovas Pharma Private Limited | Director |
| Nasreen Shabbir Ahmed | 11105035 | Viovas Pharma Private Limited | Director |
| Rajat Ranga | 11105025 | Viovas Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ruby Chaudhary
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ruby Chaudhary
Ruby Chaudhary currently holds 2 directorships: Vilarsh Healthcare Private Limited (Director, since 10 Apr 2018, revenue ₹19.52 Cr (FY 2025)); Viovas Pharma Private Limited (Director, since 28 Apr 2025, revenue ₹1.27 Cr (FY 2025)).
Ruby Chaudhary was first appointed on 10 Apr 2018 as Director at Vilarsh Healthcare Private Limited. The most recent appointment on record is 28 Apr 2025 at Viovas Pharma Private Limited.
The 2 current companies of Ruby Chaudhary that report revenue have a combined latest revenue of ₹20.79 Cr: Vilarsh Healthcare Private Limited ₹19.52 Cr (FY 2025); Viovas Pharma Private Limited ₹1.27 Cr (FY 2025).
The current boards of Ruby Chaudhary's companies include Vijay Pal Solanki (Vilarsh Healthcare Private Limited), Nasreen Shabbir Ahmed (Viovas Pharma Private Limited), Rajat Ranga (Viovas Pharma Private Limited).